# Minimally Invasive Sphincter Sparing Total Mesorectal Excision for Ultra-low Rectal Cancer After Initial Chemo-radiotherapy (MISS-TRICR).

> **NCT02488707** · PHASE2 · UNKNOWN · sponsor: **Mansoura University** · enrollment: 250 (estimated)

## Conditions studied

- Rectal Cancer

## Interventions

- **PROCEDURE:** laparoscopic intersphincteric resection (LISR group)
- **PROCEDURE:** Transanal minimally invasive Total mesorectal excision (TAMIS group)

## Key facts

- **NCT ID:** NCT02488707
- **Lead sponsor:** Mansoura University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-02
- **Primary completion:** 2016-02
- **Final completion:** 2016-04
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2015-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02488707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02488707, "Minimally Invasive Sphincter Sparing Total Mesorectal Excision for Ultra-low Rectal Cancer After Initial Chemo-radiotherapy (MISS-TRICR).". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02488707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*